These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11777464)

  • 1. Synthesis and biological activities of conformationally restricted cyclopentenyl-glutamate analogues.
    Ung AT; Schafer K; Lindsay KB; Pyne SG; Amornraksa K; Wouters R; Van der Linden I; Biesmans I; Lesage AS; Skelton BW; White AH
    J Org Chem; 2002 Jan; 67(1):227-33. PubMed ID: 11777464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
    Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
    Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity.
    Porter RH; Jaeschke G; Spooren W; Ballard TM; Büttelmann B; Kolczewski S; Peters JU; Prinssen E; Wichmann J; Vieira E; Mühlemann A; Gatti S; Mutel V; Malherbe P
    J Pharmacol Exp Ther; 2005 Nov; 315(2):711-21. PubMed ID: 16040814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
    Lavreysen H; Langlois X; Ahnaou A; Drinkenburg W; te Riele P; Biesmans I; Van der Linden I; Peeters L; Megens A; Wintmolders C; Cid JM; Trabanco AA; Andrés JI; Dautzenberg FM; Lütjens R; Macdonald G; Atack JR
    J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional calcium coupling with the human metabotropic glutamate receptor subtypes 2 and 4 by stable co-expression with a calcium pathway facilitating G-protein chimera in Chinese hamster ovary cells.
    Kowal D; Nawoschik S; Ochalski R; Dunlop J
    Biochem Pharmacol; 2003 Sep; 66(5):785-90. PubMed ID: 12948859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
    Odagaki Y; Kinoshita M; Toyoshima R
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
    Kozikowski AP; Steensma D; Araldi GL; Tückmantel W; Wang S; Pshenichkin S; Surina E; Wroblewski JT
    J Med Chem; 1998 May; 41(10):1641-50. PubMed ID: 9572889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphenyl-indanones: allosteric potentiators of the metabotropic glutamate subtype 2 receptor.
    Bonnefous C; Vernier JM; Hutchinson JH; Gardner MF; Cramer M; James JK; Rowe BA; Daggett LP; Schaffhauser H; Kamenecka TM
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4354-8. PubMed ID: 16046122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.
    Akam EC; Carruthers AM; Nahorski SR; Challiss RA
    Br J Pharmacol; 1997 Jul; 121(6):1203-9. PubMed ID: 9249258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New analogues of ACPD with selective activity for group II metabotropic glutamate receptors.
    Bräuner-Osborne H; Madsen U; Mikiciuk-Olasik E; Curry K
    Eur J Pharmacol; 1997 Aug; 332(3):327-31. PubMed ID: 9300268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
    Jullian N; Brabet I; Pin JP; Acher FC
    J Med Chem; 1999 May; 42(9):1546-55. PubMed ID: 10229625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular modeling and preliminary biological evaluation of 1-amino-3-phosphono-3-cyclopentene-1-carboxylic acid and 1-amino-3-phosphono-2-cyclopentene-1-carboxylic acid, two novel agonists of metabotropic glutamate receptors of group III.
    Amori L; Costantino G; Marinozzi M; Pellicciari R; Gasparini F; Flor PJ; Kuhn R; Vranesic I
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1447-50. PubMed ID: 10888329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
    Acher FC; Tellier FJ; Azerad R; Brabet IN; Fagni L; Pin JP
    J Med Chem; 1997 Sep; 40(19):3119-29. PubMed ID: 9301676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First enantiospecific synthesis of a 3,4-dihydroxy-L-glutamic acid [(3S,4S)-DHGA], a new mGluR1 agonist.
    Dauban P; de Saint-Fuscien C; Acher F; Prézeau L; Brabet I; Pin JP; Dodd RH
    Bioorg Med Chem Lett; 2000 Jan; 10(2):129-33. PubMed ID: 10673095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
    Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
    Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphonopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors.
    Bräuner-Osborne H; Krogsgaard-Larsen P
    Br J Pharmacol; 1998 Jan; 123(2):269-74. PubMed ID: 9489615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors.
    Bráuner-Osborne H; Nielsen B; Stensbøl TB; Johansen TN; Skjaerbaek N; Krogsgaard-Larsen P
    Eur J Pharmacol; 1997 Sep; 335(2-3):R1-3. PubMed ID: 9369383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.